The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer?
Open accessAbstract
Specific mutations in epidermal growth factor receptor (EGFR) gene are predictive for response to the EGFR tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer patients (NSCLC). According to international guidelines, the molecular testing in patients with advanced NSCLC of a non-squamous subtype is recommended. However, obtain a tissue sample could be challenging. Liquid biopsy allows to determine patients suitable for EGFR-targeted therapy by analysis of circulating-free tumor DNA (cfDNA) in peripheral blood samples and might replace tissue biopsy. It allows to acquire a material in convenient minimally invasive manner, is easily repeatable, could be used for molecular identification and molecular changes monitoring. Many studies show a high concordance rate between tissue and plasma samples testing. When U.S. Food and Drug Administration (FDA) approved the first liquid biopsy test, analysis of driver gene mutation from cfDNA becomes a reality in clinical practice for patients with NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Rosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J. M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70393-x · Cited by 5,489
Zhou, C., Wu, Y.-L., Chen, G., Feng, J., Liu, X.-Q., Wang, C., Zhang, S., Wang, J., Zhou, S., Ren, S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70184-x · Cited by 4,081
Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, I. I., Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji055 · Cited by 2,377
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
Rosell, R., Moran, T., Queralt, C., Porta, R., Cardenal, F., Camps, C., Majem, M., Lopez-Vivanco, G., Isla, D., Provencio, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904554 · Cited by 2,373
Thress, K. S., Paweletz, C. P., Felip, E., Cho, B. C., Stetson, D., Dougherty, B., Lai, Z., Markovets, A., Vivancos, A., Kuang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3854 · Cited by 1,589
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318290868f · Cited by 1,280
Peters, S., Adjei, A. A., Gridelli, C., Reck, M., Kerr, K., & Felip, E. (2012) · Annals of Oncology · doi:10.1093/annonc/mds226 · Cited by 930
Wu, Y.-L., Zhou, C., Liam, C.-K., Wu, G., Liu, X., Zhong, Z., Lu, S., Cheng, Y., Han, B., Chen, L., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv270 · Cited by 738
Reck, M., Popat, S., Reinmuth, N., De Ruysscher, D., Kerr, K. M., & Peters, S. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu199 · Cited by 679
Chabon, J. J., Simmons, A. D., Lovejoy, A. F., Esfahani, M. S., Newman, A. M., Haringsma, H. J., Kurtz, D. M., Stehr, H., Scherer, F., Karlovich, C. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms11815 · Cited by 648
Thress, K. S., Brant, R., Carr, T. H., Dearden, S., Jenkins, S., Brown, H., Hammett, T., Cantarini, M., & Barrett, J. C. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.10.004 · Cited by 493
Piotrowska, Z., Niederst, M. J., Karlovich, C. A., Wakelee, H. A., Neal, J. W., Mino-Kenudson, M., Fulton, L., Hata, A. N., Lockerman, E. L., Kalsy, A., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0399 · Cited by 458
Douillard, J.-Y., Ostoros, G., Cobo, M., Ciuleanu, T., Cole, R., McWalter, G., Walker, J., Dearden, S., Webster, A., Milenkova, T., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000263 · Cited by 448
Yung, T. K. F., Chan, K. C. A., Mok, T. S. K., Tong, J., To, K.-F., & Lo, Y. M. D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2622 · Cited by 385
Sundaresan, T. K., Sequist, L. V., Heymach, J. V., Riely, G. J., Jänne, P. A., Koch, W. H., Sullivan, J. P., Fox, D. B., Maher, R., Muzikansky, A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1031 · Cited by 347
Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas
Taniguchi, K., Uchida, J., Nishino, K., Kumagai, T., Okuyama, T., Okami, J., Higashiyama, M., Kodama, K., Imamura, F., & Kato, K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1712 · Cited by 315
Reckamp, K. L., Melnikova, V. O., Karlovich, C., Sequist, L. V., Camidge, D. R., Wakelee, H., Perol, M., Oxnard, G. R., Kosco, K., Croucher, P., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.035 · Cited by 287
Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non–Small Cell Lung Cancer
Kuang, Y., Rogers, A., Yeap, B. Y., Wang, L., Makrigiorgos, M., Vetrand, K., Thiede, S., Distel, R. J., & Jänne, P. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2592 · Cited by 232
Costa, C., Molina, M. A., Drozdowskyj, A., Giménez-Capitán, A., Bertran-Alamillo, J., Karachaliou, N., Gervais, R., Massuti, B., Wei, J., Moran, T., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2233 · Cited by 229
Wu, Y.-L., Zhong, W.-Z., Li, L.-Y., Zhang, X.-T., Zhang, L., Zhou, C.-C., Liu, W., Jiang, B., Mu, X.-L., Lin, J.-Y., et al. (2007) · Journal of Thoracic Oncology · doi:10.1097/01.jto.0000268677.87496.4c · Cited by 186
Reck, M., Hagiwara, K., Han, B., Tjulandin, S., Grohé, C., Yokoi, T., Morabito, A., Novello, S., Arriola, E., Molinier, O., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.036 · Cited by 174
Weber, B., Meldgaard, P., Hager, H., Wu, L., Wei, W., Tsai, J., Khalil, A. A., Nexø, E., & Sørensen, B. S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-294 · Cited by 154
Liu, X., Lu, Y., Zhu, G., Yao, L., Li, Z., Qin, H., Tang, C., Ellison, G., McCormack, R., & Ji, Q. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-201728 · Cited by 145
Brevet, M., Johnson, M. L., Azzoli, C. G., & Ladanyi, M. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.10.014 · Cited by 120
He, C., Liu, M., Zhou, C., Zhang, J., Ouyang, M., Zhong, N., & Xu, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24653 · Cited by 111
Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping
Kim, H.-R., Lee, S. Y., Hyun, D.-S., Lee, M. K., Lee, H.-K., Choi, C., Yang, S. H., Kim, Y., Lee, Y. C., Kim, S. Y., et al. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-50 · Cited by 109
Zhao, X., Han, R., Zhao, J., Wang, J., Yang, F., Zhong, W., Zhang, L., Li, L., & Wang, M. (2012) · Respiration · doi:10.1159/000338790 · Cited by 105
Role of circulating-tumor DNA analysis in non-small cell lung cancer
Jiang, T., Ren, S., & Zhou, C. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.09.013 · Cited by 86
Jankú, F., Huang, H. J., Claes, B., Falchook, G. S., Fu, S., Hong, D. S., Ramzanali, N. M., Nitti, G., Cabrilo, G., Tsimberidou, A. M., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0712 · Cited by 78
Nakamura, T., Sueoka‐Aragane, N., Iwanaga, K., Sato, A., Komiya, K., Kobayashi, N., Hayashi, S., Hosomi, T., Hirai, M., Sueoka, E., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31825f2821 · Cited by 75
Li, X., Ren, R., Ren, S., Chen, X., Cai, W., Zhou, F., Zhang, Y., Su, C., Zhao, C., Li, J., et al. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.04.006 · Cited by 74
The potential of liquid biopsies
Buder, A., Tomuta, C., & Filipits, M. (2016) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000267 · Cited by 67
Zhang, H., Liu, D., Li, S., Zheng, Y.-Q., Yang, X., Li, X., Zhang, Q., Qin, N., Lu, J., Ren‐Heidenreich, L., et al. (2013) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.06.006 · Cited by 52
EGFR Array: Uses in the Detection of Plasma EGFR Mutations in Non–Small Cell Lung Cancer Patients
Yam, I., Lam, D. C.-L., Chan, K., Ho, J., Ip, M., Lam, W. K., Chan, T., & Chan, V. W. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182558198 · Cited by 47
Spicer, J. F., Tischer, B., & Peters, M. J. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv128.04 · Cited by 42
Duan, H., Lu, J., Lu, T., Gao, J., Zhang, J., Xu, Y., Wang, M., Wu, H., Liang, Z., & Liu, T. (2015) · PubMed · Cited by 38
Uchida, J., Imamura, F., Kukita, Y., Oba, S., Kumagai, T., Nishino, K., Inoue, T., Kimura, M., & Kato, K. (2015) · Cancer Science · doi:10.1111/cas.12860 · Cited by 32
Rosell, R., & Rodríguez‐Abreu, D. (2014) · Springer eBooks · doi:10.1007/978-3-642-27841-9_4119-3 · Cited by 24
Administration, U. S. F. &. D. (2016) · Case Medical Research · doi:10.31525/fda1-ucm504540.htm · Cited by 23
Lv, C., Ma, Y., Feng, Q. F., Fang, F., Bai, H., Zhao, B., Yan, S., Wu, N., Zheng, Q., Li, S., et al. (2013) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-11-96 · Cited by 18
Cited by
Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies
Lo, Y. M. D., Han, D. S. C., Jiang, P., & Chiu, R. W. K. (2021) · Science · doi:10.1126/science.aaw3616 · Cited by 662
Next-generation sequencing in liquid biopsy: cancer screening and early detection
Chen, M., & Zhao, H. (2019) · Human Genomics · doi:10.1186/s40246-019-0220-8 · Cited by 556
Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis
De Rubis, G., Rajeev Krishnan, S., & Bebawy, M. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.01.006 · Cited by 535
Acoustofluidic separation of cells and particles
Wu, M., Ozcelik, A., Rufo, J., Wang, Z., Fang, R., & Jun Huang, T. (2019) · Microsystems & Nanoengineering · doi:10.1038/s41378-019-0064-3 · Cited by 453
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
Keller, L., Belloum, Y., Wikman, H., & Pantel, K. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01047-5 · Cited by 401
Metadata
- Authors
- Kwapisz, D.
- Venue
- Annals of Translational Medicine
- Publisher
- AME Publishing Company
- Published
- 2017-02
- Volume
- 5
- Issue
- 3
- Pages
- 46-46
- ISSN
- 2305-5839 (ISSN-L)
- 2305-5847
- OpenAlex
- W2975734135
- Cited by
- 271
- References
- 42
- FWCI
- 25.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.